Medical Devices Europe

Europe Prenatal Genetic Testing Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Europe Prenatal Genetic Testing Market Industry Trends and Forecast to 2034: Segmented by (Test, Condition, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Europe · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.12 Bn Placeholder estimate
Estimate 2025 $1.22 Bn 18.3% of the global market
Projected 2034 $2.63 Bn 115.4% Adds $1.41 Bn over 9 forecast years
CAGR 2025–2034 8.9% Faster than 61% of 173 Medical Devices markets here
Key players 5
  • Europe is 18.35% of the global market.
  • Among regions, the largest is North America at $3.24 Bn.
  • Fastest growing: Africa at 11.6% a year.
  • Europe ranks 3rd of 6 by size among regions.

Market size projection

Europe

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.41 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Prenatal Genetic Testing Market market size by year, Europe
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.12 Bn — —
2025 (base) $1.22 Bn +$99.8 Mn —
2026 (forecast) $1.33 Bn +$108.7 Mn +8.9%
2027 (forecast) $1.45 Bn +$118.3 Mn +18.6%
2028 (forecast) $1.58 Bn +$128.9 Mn +29.1%
2029 (forecast) $1.72 Bn +$140.3 Mn +40.6%
2030 (forecast) $1.87 Bn +$152.8 Mn +53.2%
2031 (forecast) $2.04 Bn +$166.4 Mn +66.8%
2032 (forecast) $2.22 Bn +$181.3 Mn +81.6%
2033 (forecast) $2.42 Bn +$197.4 Mn +97.8%
2034 (forecast) $2.63 Bn +$214.9 Mn +115.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Europe Prenatal Genetic Testing Market Analysis at a glance
Market size, 2025$1.22 Bn placeholder estimate
Forecast, 2034$2.63 Bn placeholder estimate
Growth (CAGR), 2025–20348.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, condition and end user (see all)
Key playersIllumina, Inc., Natera, BGI Genomics, Roche Diagnostics, Myriad Genetics, Inc. (see all)
Regulator in EuropeEU MDRSource: European Commission, medical devices. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Europe Prenatal Genetic Testing Market Analysis Executive Summary

Prenatal genetic tests, such as non-invasive prenatal tests, check a baby's DNA for genetic conditions during pregnancy, often from the mother's blood.

Key segments of the prenatal Genetic Testing market include test (NIPT, Carrier Screening and Amniocentesis Testing) and condition (Down Syndrome, Sex Chromosome Disorders and Microdeletions).

Bar chart: Europe Prenatal Genetic Testing market size, 2024–2034, placeholder estimates. $1.12 Bn in 2024, $1.22 Bn in 2025 and $2.63 Bn in 2034, 8.9% CAGR.
Europe Prenatal Genetic Testing market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Europe Prenatal Genetic Testing Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the prenatal Genetic Testing market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the prenatal Genetic Testing market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the prenatal Genetic Testing market.

Competitive Landscape for Prenatal Genetic Testing Market in Europe

The prenatal Genetic Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Prenatal Genetic Testing Market in Europe

Prenatal Genetic Testing in Europe: rules and payment

In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first.⁠[1] In the countries we cover here, medical devices are regulated by ANSM (France)⁠[2], BfArM (Germany)⁠[3], Ministry of Health (Italy)⁠[4], Roszdravnadzor (Russia)⁠[5], AEMPS (Spain)⁠[6] and MHRA (UK)⁠[7]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.⁠[8]

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how prenatal Genetic Testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Europe.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Prenatal Genetic Testing right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Prenatal Genetic Testing in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Prenatal Genetic Testing market in Europe?
Placeholder estimate: about $1.22 Bn in 2025, rising to about $2.63 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Prenatal Genetic Testing market in Europe growing?
Placeholder estimate: about 8.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Prenatal Genetic Testing market report cover?
The report splits the market by test (NIPT, Carrier Screening, Amniocentesis Testing, CVS Testing), condition (Down Syndrome, Sex Chromosome Disorders, Microdeletions) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Prenatal Genetic Testing market?
Key players include Illumina, Inc., Natera, BGI Genomics, Roche Diagnostics and Myriad Genetics, Inc..
What is driving the Prenatal Genetic Testing market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the prenatal Genetic Testing market.
Who regulates Prenatal Genetic Testing in Europe?
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first. Source: European Commission, medical devices. Checked 14 Nov 2026.
How is healthcare paid for in Europe?
Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines. Source: European Commission, health technology assessment. Checked 14 Nov 2026.
How much research is published on Prenatal Genetic Testing?
PubMed lists 242 papers on Prenatal Genetic Testing added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Europe

See all

Related on diagnostics and lab testing and maternal

See the topic